Biomarker and Companion Diagnostics—A Review of Medicinal Products Approved by the European Medicines Agency

Background: An increasing number of medicines authorised in Europe recommend or require biomarker-based patient selection. For some of these the use of a companion diagnostic (CDx), a subset of in vitro diagnostics (IVDs), to identify patient populations eligible for a specific medicinal product may...

Descripción completa

Detalles Bibliográficos
Autores principales: Orellana García, Laura Patricia, Ehmann, Falk, Hines, Philip A., Ritzhaupt, Armin, Brand, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591033/
https://www.ncbi.nlm.nih.gov/pubmed/34790681
http://dx.doi.org/10.3389/fmed.2021.753187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591033/
https://www.ncbi.nlm.nih.gov/pubmed/34790681
http://dx.doi.org/10.3389/fmed.2021.753187

Ejemplares similares